Skip to Content

Cromolyn ophthalmic Pregnancy and Breastfeeding Warnings

Cromolyn ophthalmic is also known as: Crolom, Opticrom

Cromolyn ophthalmic Pregnancy Warnings

Cromolyn ophthalmic has been assigned to pregnancy category B by the FDA. Animal studies using doses up to 205 times the normal human dose have revealed no evidence of teratogenicity. Increased fetal resorption and decreased fetal weight occurred at maternotoxic parenteral doses. There are no controlled data in human pregnancy; however, data available suggest cromolyn use in human pregnancy is not associated with fetal toxicity or teratogenicity. Systemic absorption is minimal after ocular administration (0.03% of a dose). Cromolyn should only be given during pregnancy when the need has been clearly established.

See references

Cromolyn ophthalmic Breastfeeding Warnings

There are no data on the excretion of cromolyn into human milk. Systemic absorption is insignificant after ocular administration (0.03% of a dose). The manufacturer recommends that caution be used when administering cromolyn ophthalmic to nursing women.

See references

References for pregnancy information

  1. "Product Information. Opticrom (cromolyn sodium ophthalmic)." Allergan Inc, Irvine, CA.

References for breastfeeding information

  1. "Product Information. Opticrom (cromolyn sodium ophthalmic)." Allergan Inc, Irvine, CA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.